Influence of daptomycin doses on the outcomes of VRE bloodstream infection treated with high-dose daptomycin

YU-CHUNG CHUANGHSIN-YI LINYang, Jia LingJia LingYangLin, Chi YingChi YingLinHuang, Sung HsiSung HsiHuangJANN-TAY WANGYEE-CHUN CHENSHAN-CHWEN CHANG2022-09-022022-09-022022-07-280305-7453https://scholars.lib.ntu.edu.tw/handle/123456789/617772The CLSI recommended high-dose daptomycin (8-12 mg/kg) for treating Enterococcus faecium bloodstream infections (BSI). The current study was designed to determine the safety and efficacy of increasing the daptomycin dose for VRE BSI patients receiving ≥8 mg/kg.enVANCOMYCIN-RESISTANT; ENTEROCOCCUS-FAECIUM; CLINICAL-OUTCOMES; BACTEREMIA; SAFETY; COMBINATION; AMPICILLIN; FAECALIS; THERAPY; COHORTInfluence of daptomycin doses on the outcomes of VRE bloodstream infection treated with high-dose daptomycinjournal article10.1093/jac/dkac164356395862-s2.0-85136064530WOS:000805223600001https://api.elsevier.com/content/abstract/scopus_id/85136064530